ARCHIVES

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Agrees: Three Dyes, Hair Color Agent Are Carcinogens; Risk To Humans – Brown

May 5, 1978

T-Cell Vaccines Cut Time To Protective Immunity

November 25, 2005

AACR Reschedules Annual Meeting For July 11-14, in Washington, DC

April 25, 2003

NCI, American Cancer Society Re-Evaluating Join Guidelines On Mammography Screening

September 17, 1993

Gallo Inquiry Complete; NCAB’s AIDS Committee Plans Q&A Session

June 12, 1992

Russian-American Breast Cancer Meeting Canceled

April 14, 1995